Table 4.
Group | FSH (ng/ml) | LH (ng/ml) | (E2) (ng/ml) | Progesterone (ng/ml) | AMH (ng/ml) |
---|---|---|---|---|---|
Control | 8.22 ±1.23 | 4.11 ± 0.65 | 70.98 ± 1.4 | 40.98 ± 0.9 | 9.44 ± 0.66 |
Cisplatin | 19.98 ± 0.98a | 9.2 ± 1.09 a | 20.65 ± 0.9 a | 12.09 ± 0.32 a | 4.76 ± 0.31 a |
RJ+Cis | 9.65 ± 0.45 b | 5.25 ± 0.45b | 75.12 ± 1.4b | 35.12 ± 1.07 b | 8.21 ± 0.28b |
Values were expressed as mean±SD. (RJ): Royal jelly, FSH: Follicular stimulating hormone, (LH): Luteinizing hormone, (E2): Estradiol 2, (AMH): Anti-mullerian hormone
a: indicates a significant difference (P<0.05) when compared to the control group. b: indicates a significant difference (P<0.05) when compared to the cisplatin group